Skip to main content

Pentasa

Generic: mesalamine

Data may be stale·Apr 23, 2026
Manufacturer
Takeda
NDC
54092-189
RxCUI
206791
Route
ORAL
ICD-10 indication
K51.9

Affordability Check

How much will you actually pay for Pentasa?

In 30 seconds, see every legitimate way to afford Pentasa — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Pentasa

What is this medication? Pentasa is a prescription medication that contains the active ingredient mesalamine, which belongs to a class of drugs known as aminosalicylates. It is primarily used to treat and manage inflammatory bowel diseases, specifically ulcerative colitis. The medication works locally in the digestive tract to reduce inflammation, swelling, and tissue damage in the lining of the colon and rectum, which helps to alleviate symptoms such as rectal bleeding, stomach pain, and frequent diarrhea.

In addition to treating active flare-ups of mild to moderate ulcerative colitis, Pentasa is often prescribed as a maintenance therapy to help patients stay in remission. By controlling the underlying inflammation over the long term, the drug helps prevent the recurrence of symptoms. While it is most commonly associated with ulcerative colitis, some healthcare providers may also use it to manage certain cases of Crohn's disease that affect the colon. It is typically administered as extended-release capsules designed to release the medication gradually throughout the intestinal tract.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How Pentasa appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).

Covered by plans

21%

1,175 of 5,499 plans

Most common tier

Tier 4

On 71% of covering formularies

Prior authorization required

0%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)5
14%
Tier 2 (generic)2
6%
Tier 3 (preferred brand)3
9%
Tier 4 (non-preferred brand)25
71%

Step therapy: 0% of formularies

Quantity limits: 71% of formularies

Coverage breadth: 35 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

—

Medicare Part D

———

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.